VioQuest Pharmaceuticals, Inc. (VOQP)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.08 Million | -6.45 Million | -3.74 Million | -3.78 Million | -1.63 Million | -115.95 Thousand |
| Net Income | -10.89 Million | -8.27 Million | -12.83 Million | -4.02 Million | -2.01 Million | -51.88 Thousand |
| Depreciation & Amortization | 1.2 Million | 6304.00 | 266.51 Thousand | 475.41 Thousand | 323.51 Thousand | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.64 Million | 349.7 Thousand | 490.97 Thousand | -238.03 Thousand | 57.95 Thousand | -11.95 Thousand |
| Other non-cash items | 1.48 Million | 864.54 Thousand | - | - | - | - |
| Investing Cash Flow | 1.69 Million | -281.54 Thousand | -785.7 Thousand | -549.02 Thousand | -368.08 Thousand | 149.22 Thousand |
| Investments in PPE | -5127.00 | -28.4 Thousand | -615.46 Thousand | -356.54 Thousand | -237.22 Thousand | - |
| Acquisitions | - | - | -170.23 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -192.48 Thousand | -130.86 Thousand | - |
| Financing Cash Flow | 3.15 Million | 3.64 Million | 7.48 Million | 6.74 Million | 2.63 Million | 3.16 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 3.64 Million | 7.74 Million | 6.74 Million | - | 3.24 Million |
| Other Financing Activities | - | - | - | - | 2.96 Million | -200.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -265.01 Thousand | -283.25 Thousand | -48.47 Thousand | 6474.00 |
| Other working capital | 102 Thousand | - | - | - | - | - |
| Cash at beginning of period | 2.93 Million | 6.02 Million | 3.06 Million | 659.11 Thousand | 33.52 Thousand | 8150.00 |
| Cash at end of period | 694.55 Thousand | 2.93 Million | 6.02 Million | 3.06 Million | 659.11 Thousand | 3.21 Million |
| Capital Expenditure | -5127.00 | -28.4 Thousand | -615.46 Thousand | -356.54 Thousand | -237.22 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.23 Million | -3.09 Million | 2.95 Million | 2.4 Million | 625.59 Thousand | 3.2 Million |
| Free Cash Flow | -7.08 Million | -6.48 Million | -4.35 Million | -4.14 Million | -1.87 Million | -115.95 Thousand |
| Breakdown | 2008 Q2 | 2008 Q1 | 2007 Q4 | 2007 FY | 2007 Q3 | 2007 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.83 Million | -3.08 Million | -3.01 Million | -10.89 Million | -2.88 Million | -2.47 Million |
| Depreciation & Amortization | 2325.00 | 2325.00 | 635 Thousand | 1.2 Million | 565.35 Thousand | 1819.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -731.12 Thousand | 451.12 Thousand | 26.59 Thousand | 1.64 Million | 150.66 Thousand | 830.99 Thousand |
| Other non-cash items | 1.02 Million | 1.56 Million | 595.46 Thousand | 1.48 Million | 303.83 Thousand | 313.87 Thousand |
| Investing Cash Flow | - | - | - | 1.69 Million | 1.72 Million | -3143.00 |
| Investments in PPE | - | - | - | -5127.00 | -2850.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.05 Million | 671.45 Thousand | - | 3.15 Million | 528.03 Thousand | 2.69 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.05 Million | 671.45 Thousand | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 9415.00 | 8911.00 | 44.17 Thousand | 102 Thousand | -81.6 Thousand | 240.34 Thousand |
| Cash at beginning of period | 305.56 Thousand | 694.55 Thousand | 2.45 Million | 2.93 Million | 2.83 Million | 1.14 Million |
| Cash at end of period | 814.47 Thousand | 305.56 Thousand | 694.55 Thousand | 694.55 Thousand | 2.45 Million | 2.83 Million |
| Capital Expenditure | - | - | - | -5127.00 | -2850.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 508.91 Thousand | -388.99 Thousand | -1.76 Million | -2.23 Million | -374.21 Thousand | 1.68 Million |
| Free Cash Flow | -1.54 Million | -1.06 Million | -1.76 Million | -7.08 Million | -2.62 Million | -1 Million |
QH-R
6395
3332
605005
IESVF
002185